Webinar: Medical Operations

Medical Operations Under Scrutiny

Medical Operations in Australia's pharmaceutical and medtech sectors encompasses the medical governance of clinical trials, including physician oversight, medical monitoring, safety assessments, and strategic input into trial design and execution. These functions bridge clinical development with regulatory compliance, ensuring trials meet ethical and scientific standards while protecting participant safety.

The topic has gained urgency in 2026 as Australia's clinical trials landscape grows rapidly, driven by government investments in a National One Stop Shop for trials and increased focus on advanced therapies like cell and gene products. This expansion amplifies the demands on medical operations professionals to handle complex protocols, real-time data monitoring, and interactions with ethics committees and the Therapeutic Goods Administration (TGA).

Recent TGA moves have intensified the spotlight. The adoption of ICH E6(R3) Good Clinical Practice guidelines, finalised in late 2025, introduces stricter expectations for risk-based monitoring and sponsor oversight, placing greater responsibility on medical operations teams to demonstrate robust medical review processes. Similarly, updates to pharmacovigilance standards align Australia closer to EMA frameworks, requiring enhanced medical input into post-trial safety data handling.

The stakes are high. Non-compliance can trigger trial holds, data invalidation, or penalties, delaying market access for therapies and costing sponsors millions in lost revenue. Participants face heightened risks if medical oversight falters, while companies grapple with talent shortages in specialised roles—exacerbated by competition from global hubs. A non-obvious tension lies in balancing operational efficiency with rigorous medical scrutiny: overly cautious approaches slow trials, yet lax ones invite regulatory intervention.

ARCS Australia's interest area webinars, including this one, signal the industry's push to build capability in this area through peer discussion of trends and challenges, especially as workforce capacity remains a bottleneck despite reform momentum.